The Latest News
BiomimX interview at STARTUPPER
2ND WORKSHOP ON NEXT GEN ORGAN-ON-CHIP & ORGANOIDS – Geneva, August 23-24
We are happy to announce that BiomimX is going to be one of the exhibitors in the 2nd networking workshop on Next Gen Organ-On-Chip & Organoids to be held on August 23-24 in Geneva.
Also, our CEO, Paola Occhetta is going to present “Beating organs-on-chip for human organs and diseases modeling: advanced preclinical tools for screening drugs and medical devices” on August 23 at 2PM.
Come to our booth and take the opportunity to discover how our Beating Organs-on-Chip will reshape the future of drug discovery!
EUROOCS 2022 – Grenoble, July 4-5
BiomimX is silver sponsor at #EUROoCS Annual meeting. We believe that Organs on Chip will change the future and for this reason we are happy to support our European Organs on Chip Society. Meet us in Grenoble to learn more about our Beating Organs on Chip solutions.
BIO 2022 – San Diego, June 13-16, 2022
We are thrilled to announced that the European Commission choose BiomimX among the 20 EU SMEs that will represent Europe during the BIO 2022 in San Diego! We are looking forward for an exciting exhibition week at the European Pavillon! Stay posted, more news will come!
May 30 – June 3, 2022
Do you want to know more about BiomimX’s latest scientific advancement in developing human microphysiological systems? Join us in New Orleans at the MPS World Summit and learn directly from our Team about uKnee, uHeart and uScar models!
May 6, 2022 – ECTS
Save the date! Our collaborator OncoBone Ventures Limited is participating to the European Calcified Tissue Society Conference in Helsinki from May 6 to May 10, 2022. Don’t miss the chance to be updated on our uKnee model, presented by Tiina Kähkönen during the pre-congress session “Osteoarthritis and Bone” on May 6.
While also the startups that won the second edition of Cross The Bridge are taking the next steps in their projects, in this article StartupItalia recalls the four winners of the very first edition, including BiomimX.
We’re happy we took this opportunity !
4th Webinar on Wednesday, April 27, at 4 pm (GMT+2)
In this webinar our COO Roberta Visone is presenting uScar, a model of cardiac fibrosis developed by exploiting BiomimX® uStretch platforms and used in collaboration with Prof. Valeria Chiono from Politecnico di Torino to test advanced cardiac reprogramming therapeutics.
CEN-CENELEC Focus Group on Organ on Chip
On March 2nd, 2022 we participated to the Standards for Organ-on-Chip Focus Group Kick-off Meeting. We are excited to give our contribution in drafting standards in OoC!
The Focus Group shall ensure interaction between all relevant European stakeholders interested in potential standardization in the field of OoC. The Focus Group has been established by European standards organizations CEN and CENELEC with a secretariat by the Dutch organization for standards, NEN
We’re proud to be part of the The North American 3Rs Collaborative (NA3RsC) Microphysiological Systems (MPS) initiative.
The MPS initiative works together to increase industry adoption and regulatory acceptance of MPS technologies with the ultimate goal of refining, reducing, and replacing research animals.
We are happy to share that our CEO, Paola Occhetta, has been selected among the 50 female entrepreneurs supported by the first call of the WomenTech EU program! Stay tuned to know how this exciting program will help us accelerating our vision!
March 11, 2022
We are participating to CellToxDays 2022! Paola Occhetta, CEO of BiomimX, is presenting “Beating Organs-on-Chip: from single functional tissues to multiorgan models” on March 11th, at 10.40 AM (CET).
December 7, 2021
Biofit 2021 is coming in few weeks, and we are ready!
Paola Occhetta is presenting BiomimX® Srl during the Startup Slams in the 3D culture session on Tuesday, December 7, at 11.30 CET.
Don’t miss this opportunity!
We are glad to partecipate to Termis World Congress 2021. Paola Occhetta, CEO of BiomimX, is presenting “3D in vitro models for drug screening and toxicology: experiences from the EU H2020 project SINERGIA and the EURION cluster”.
October 1, 10.00 am CEST
We’re glad to communicate that Paola Occhetta, BiomimX® Srl CEO, will present “Beating organs-on-chip as technological platforms in drug screening: advanced in vitro models of human physiology and pathology” at Centro 3R third Annual Convention, on October 1 at 10.00 am.
Save the date!
September 30, 2021
We’ll be at EIC Corporate Day with Merck!
We are already excited about possible future collaborations that may arise from this experience.
BiomimX® Srl will be represented by our CEO Paola Occhetta.
September 29 – October 1, 2021
We’ll be at the next Meet in Italy for Life Sciences 2021! Our CEO, Paola Occhetta, is representing BiomimX® Srl on September 29 – October 1. Don’t miss the opportunity to know more about our innovation and technology.
September 17, 2021
Milano, 17/09/2021. Fidia Farmaceutici S.p.A. and BiomimX® Srl have signed a research collaboration agreement aimed at introducing and applying new Organs-on-Chip based technological solutions to the intra-articular medical device discovery process.
September 15, 14.30-15.30 CEST
Save the date! Upcoming webinar on Wednesday 15th September, 14.30-15.30 CEST. Within the SINERGIA2020 framework we are glad to announce that Professor Bart Spee is going to present a webinar on Liver organoids for advanced in vitro models and whole organ engineering.
June 30, 2021
Milano, 30th June 2021. Accelera – Part of NMS Group and BiomimX® Srl have signed a non-exclusive commercial agreement following an intense scientific collaboration aimed at introducing and applying new technological solutions to the drug discovery process.
June 10, 2021 3pm-4pm CEST
We are glad to announce that our CEO Paola Occhetta is presenting BiomimX® innovative solutions on the occasion of our win for the CrossTheBRIDGE2021.
June 16, 2021 4PM (GMT+2)
The second BiomimX Webinar is on its way, and we’re having a special guest this time! Together with Simona Marzorati, head of Laboratory at Accelera – Part of NMS Group , our COO Roberta Visone will present the potential of uHeart model throughout drug discovery and development. Don’t miss this! Register here
May 20, 2021
We are very pleased to announce that BiomimX® won first place in the 2021 Cross the Bridge competition called by Camera di Commercio Milano Monza Brianza Lodi, earning a 50.000 € prize to implement its project activities.
April 21, 2021
We are glad to announce that our CEO Paola Occhetta is participating to the Organ-on-a-Chip Symposia Series the 21st of April 2021.
She will talk about our human Osteoarthritic (OA) model uKnee and its potential as a tool for testing efficacy of anti-OA drugs and intra-articular medical devices.
Don’t miss it! Register now.
March 24, 2021 4PM (GMT+1)
Towards the replication of human complexity in vitro, we have developed uBeat® technology which allows to take the first steps to mimic human tissues behavior with an unprecedented precision.
Why not planning your next experimental campaign with something that could give you more flexibility and a better representation of clinical insights?
Learn more about uBeat® technology on our first free webinar.
February 9, 2021
We are glad to announce that our latest study “Micro-electrode channel guide (µECG) technology: an online method for continuous electrical recording in a human beating heart-on-chip” is now on-line on Biofabrication.
In this paper we present a new device capable of monitoring the electrical activity of beating cardiac microtissues, together with a proof-of-concept pharmacological validation.
This work is the result of a great collaboration between Academia (Politecnico di Milano) and Industries (BiomimX® Srl & Accelera Srl).
January 21, 2021 (8 PM CET)
2020 has taught us how crucial is to invest in Research, mostly to reduce technical time for testing drugs and medical devices.
Paola Occhetta, BiomimX CEO, and Marco Rasponi, BiomimX President, will explain how our startup contributes to bring pharmaceutical companies to the market with more efficient therapies in a shorter time, thanks to our innovative technologies.
Don’t miss the episode of STARTUPPER broadcast on Thursday 21st January starting at 8 PM CET on channel 821 Sky.
January 20, 2021 (2.30-3.30 PM CET)
Upcoming webinar! Within the SINERGIA framework we are glad to announce that professor Paul Bourgine will be the first speaker of our webinars series, invited by BiomimX® Srl. Prof. Bourgine’s laboratory targets the development of miniaturized human bone organs (hOssicles) in mice to be used as advanced model of healthy and malignant human hematopoiesis. This talk will first cover how embryonic processes can be harnessed for the engineering of hOssicles. The advantages of the hOssicle approach as opposed to standard in vitro and in vivo models will be discussed.
December 7th-10th , 2020
BiomimX® will partecipate to the Digital Biofit 2020 from December 7th to December 10th 2020. We are looking forward to virtually meet you during the one-to-one partnering event and to take part to this exiting Life Science fair!
July 29th, 2020
We are glad to announce that today our company name, BiomimX®, and our technology name, uBeat®, have both received the trademark registration.
Stefano Piazza, Roberta Visone from BiomimX S.r.l., Simona Marzorati from Accelera and Erika Ferrari from Politecnico di Milano joined the #EUvsVIRUS hackaton, conceiving tha “BeatingCovidOnChip”, an innovative microfluidic platform to speed up the drug screening process for Covid-19 treatments.
#BeatMyCovid to #BeatThemAll!
BiomimX® Srl winner of the prize #DigitalForHealth. Thanks to Consorzio DAFNE for the opportunity!
BiomimX® obtains the SME Instrument phase 1
Thanks to the SME Instrument Phase 1awarded for the project uHeart, BiomimX® will accelerate its way to the market!
Best poster award at the Safety Pharmacology Society 2019 Annual Meeting
In a collaborative project of BiomimX®, Politecnico di Milano and Accelera S.r.l., Roberta Visone was awarded the first place in the 2019 Jr. Investigator Poster Contest at the Safety Pharmacology Society 2019 Annual Meeting. September 23-26, 2019, Barcelona, Spain.
Visone R, Marzorati S, Perego V, Occhetta P, Pesenti E,Rasponi M. “uHeart: a beating heart-on-chip platform for on-line recording of functional 3D cardiac microtissues’ electrical activity”
SINERGIA project (MSCA-ITN-ETN-2019) was financed by EU Commission
BiomimX® is part of the SINERGIA network. SINERGIA aims to provide breakthrough strategies for the implementation of new in vitro preclinical platforms in terms of innovative technologies, biological models and drug screening approaches in the effort of bridging the gap between current, simplistic in vitro cultures and faithful and effective future physiological models. More info here!
BiomimX® receives its third Seal of Excellence H2020 from the European Commission!
BiomimX® won the 3rd prize at the “EIT Joint Grand Final” in Budapest
On 16th November 201, BiomimX® was awarded the third prize in the competition HeadStart Funding, which was created to accelerate products and solutions in SMEs and bring the companies to an investment-ready stage.
BiomimX® receives a new Seal of Excellence H2020 from the European Commission
BiomimX® was awarded the First Prize at the Business Plan Competition at TERMIS 2018!
BiomimX® was awarded the First Prize in the Business Plan Competition in Kyoto, during the 5th World Congress of the Tissue Engineering and Regenerative Medicine International Society (Kyoto, Japan).
BiomimX® in Naples for the European Health Catapult and Headstart regional selection event
BiomimX® participated to the final selection, and it was voted as one of the best 8 Teams in the Headstart program. Besides being awarded a prize money (€35,000), our Team will have the possibility to mature its business plan, negotiation and pitching skills as well as to learn from experts thanks to EIT.
BiomimX® at Lab on a chip Symposium in Basel
BiomimX® will participate to the Lab on a chip Symposium – from molecular assays to organs on a chip organized in Basel by The Royal Society of Chemistry journal Lab on a Chip and ETH Zurich.
BiomimX® receives its first Seal of Excellence H2020 from the European Commission
BiomimX® at Bootcamp of BioInItaly/StartUp Initiative 2018 by Intesa Sanpaolo
BiomimX® has been selected and invited to the training and selection phase of the BioInItaly/StartUp Initiative 2018, in the Biotech track. Intesa Sanpaolo Start-Up Initiative is a comprehensive program aimed at technology start-ups looking for concrete business opportunities: every few months, a rigorous selection and training process leads the best start-ups to high-profile, technology-specific events called Arena Meetings, where they can pitch to international investors and corporations.
SNSF/Innosuisse BRIDGE PoC grant for Knee-on-chip
Paola Occhetta was awarded the SNSF/CIT BRIDGE Proof-of-Concept grant for developing a Knee-on-chip platform to speed up the research for anti-osteoarthritic drugs. She will receive 130,000 Swiss francs in funding to implement her project within a collaboration between University Hospital of Basel and BiomimX®.
BiomimX® at Bioindustry Park thanks to Premio Marzotto
BiomimX® has classified among the 10 finalists of Premio Marzotto 2017 – Dall’idea all’impresa with its uKnee model. With its idea, BiomimX® was awarded with one year of mentoring and incubation at Bioindustry Park, a startup incubator located in Ivrea (Italy). Bioindustry Park, lead by Silvano Fumero, is the ideal location and solution to companies in need of efficiency, quality and image.
BiomimX® was founded after winning StartCup Lombardia 2016, in the category of Life Science & Agrofood with its uBeat® technology.
BiomimX® among 10 finalists of Bioupper 2015
BiomimX® has classified among the 10 finalists of the first edition of Bioupper – Let’s give life to life Startups, the empowerment acceleration program for LifeTech startups organized by Novartis and Fondazione Cariplo.